Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.28
-0.57 (-5.25%)
At close: Jan 28, 2026, 4:00 PM EST
10.28
0.00 (0.00%)
Pre-market: Jan 29, 2026, 7:30 AM EST
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $2.19 billion as of January 29, 2026. Its market cap has increased by 69.67% in one year.
Market Cap
2.19B
Enterprise Value
1.92B
1-Year Change
69.67%
Ranking
Category
Stock Price
$10.28
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $2.19B, an increase of 709.66%. That is a compound annual growth rate of 19.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 2.31B | -10.62% |
| Dec 31, 2025 | 2.59B | 92.64% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
| Jul 25, 2014 | 270.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 2.44B |
| Mesoblast | 2.42B |
| Recursion Pharmaceuticals | 2.39B |
| Ultragenyx Pharmaceutical | 2.37B |
| Ascentage Pharma Group International | 2.33B |
| Sarepta Therapeutics | 2.32B |
| Soleno Therapeutics | 2.32B |
| Galapagos NV | 2.29B |